Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk

The search for potential biomarkers of psychiatric disorders is a central topic in biological psychiatry. This review concerns published studies on potential biomarkers of treatment-resistant depression (TRD). The search for biomarkers of TRD in the bloodstream has focused on cytokines and steroids...

Full description

Bibliographic Details
Main Author: Donald F Smith
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-06-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fpsyt.2013.00057/full
id doaj-c66aeeeef5bb48ef8b916741d126fcbd
record_format Article
spelling doaj-c66aeeeef5bb48ef8b916741d126fcbd2020-11-24T23:38:56ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402013-06-01410.3389/fpsyt.2013.0005755493Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward riskDonald F Smith0Psychiatric Hospital of Aarhus UniversityThe search for potential biomarkers of psychiatric disorders is a central topic in biological psychiatry. This review concerns published studies on potential biomarkers of treatment-resistant depression (TRD). The search for biomarkers of TRD in the bloodstream has focused on cytokines and steroids as well as brain-derived neurotropic factor. Additional approaches to identifying biomarkers of TRD have dealt with cerebrospinal fluid analysis, magnetic resonance imaging, and positron emission tomography. Some studies have also investigated potential genetic and epigenetic factors in TRD. Most studies have, however, used a post hoc experimental design that failed to determine the association between biomarkers and the initial risk of TRD. Particular attention in future studies should be on shifting the experimental paradigm towards procedures that can determine the risk for developing treatment resistance in untreated depressed individuals.http://journal.frontiersin.org/Journal/10.3389/fpsyt.2013.00057/fullCytokinesImmune Systembrain imagingbiomarkersdepressive disordersexperimental design
collection DOAJ
language English
format Article
sources DOAJ
author Donald F Smith
spellingShingle Donald F Smith
Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk
Frontiers in Psychiatry
Cytokines
Immune System
brain imaging
biomarkers
depressive disorders
experimental design
author_facet Donald F Smith
author_sort Donald F Smith
title Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk
title_short Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk
title_full Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk
title_fullStr Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk
title_full_unstemmed Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk
title_sort quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk
publisher Frontiers Media S.A.
series Frontiers in Psychiatry
issn 1664-0640
publishDate 2013-06-01
description The search for potential biomarkers of psychiatric disorders is a central topic in biological psychiatry. This review concerns published studies on potential biomarkers of treatment-resistant depression (TRD). The search for biomarkers of TRD in the bloodstream has focused on cytokines and steroids as well as brain-derived neurotropic factor. Additional approaches to identifying biomarkers of TRD have dealt with cerebrospinal fluid analysis, magnetic resonance imaging, and positron emission tomography. Some studies have also investigated potential genetic and epigenetic factors in TRD. Most studies have, however, used a post hoc experimental design that failed to determine the association between biomarkers and the initial risk of TRD. Particular attention in future studies should be on shifting the experimental paradigm towards procedures that can determine the risk for developing treatment resistance in untreated depressed individuals.
topic Cytokines
Immune System
brain imaging
biomarkers
depressive disorders
experimental design
url http://journal.frontiersin.org/Journal/10.3389/fpsyt.2013.00057/full
work_keys_str_mv AT donaldfsmith questforbiomarkersoftreatmentresistantdepressionshiftingtheparadigmtowardrisk
_version_ 1725515261030694912